HMDCF Company Profile and Key Details
HUTCHMED (China)
Price Chart
Stock Price Today
HUTCHMED (China) Limited (HMDCF) stock remained unchanged at $2.16 a share on OTC. The stock opened at $3.82, fluctuating between $2.16 to $3.82 during the session.
Stock Snapshot
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 09, 2026 | 2.82 | 2.82 | 2.82 | 2.82 | 1.5K |
| Jan 15, 2026 | 3.02 | 3.02 | 3.02 | 3.02 | 10K |
| Jan 07, 2026 | 3.19 | 3.19 | 3.19 | 3.19 | 1K |
| Sep 30, 2025 | 3.66 | 3.66 | 3.66 | 3.66 | 356 |
| Sep 18, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Sep 15, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Sep 11, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Sep 08, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Sep 04, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Sep 02, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 468 |
| Aug 26, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Aug 22, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 468 |
| Aug 15, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Aug 12, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Aug 11, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Aug 08, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Aug 06, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Aug 05, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Aug 04, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
| Jul 31, 2025 | 3.20 | 3.20 | 3.20 | 3.20 | 0 |
Contact Details
About Company
HUTCHMED (China) Ltd. operates as a holding company, specializing in the research, development, manufacturing, and sales of both pharmaceutical products and health-focused consumer goods. The company's operations are divided into two main segments: Oncology/Immunology and Other Ventures. The Oncology/Immunology division is dedicated to the discovery, development, and commercialization of targeted therapies and immunotherapies aimed at treating cancer and immunological diseases. In contrast, the Other Ventures segment handles the company's other commercial activities, which include the marketing, production, and distribution of prescription medications and general healthcare products. Established on December 18, 2000, the company maintains its headquarters in Hong Kong.
Company Information
| Employees | 1796 |
| Beta | 0.43 |
| Sales or Revenue | $839.96M |
| 5Y Sales Change% | 2.06% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Stock Peers
Frequently Asked Questions
Chief Executive Officer, Chief Scientific Officer & Executive Director
Mr. Charles George Rupert Nixon
Group Gen. Counsel
Mr. Chig Fung Cheng BEc, CA
Chief Financial Officer & Executive Director
Dr. Karen Jane Atkin
Executive Vice President & Chief Operating Officer
Mr. Kin Hung Lee M.B.A.
Senior Vice President of Corporation Fin. & Devel.
Dr. Qingmei Wang Ph.D.
Senior Vice President of Bus. Devel. & Strategic Alliances
Mr. Chi Keung To ACGI, B.Sc., BSc, M.B.A., MBA
Executive Chairman
Mr. Hong Chen
Senior Vice President & Chief Commercial Officer- China
Dr. Wei-Guo Su B.Sc., Ph.D.
Chief Executive Officer, Chief Scientific Officer & Executive Director
Dr. Zhenping Wu M.B.A, Ph.D.
Executive Vice President of Pharmaceutical Science & Manufacturing
Ms. Selina Zhang
Senior Vice President of Global HR
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep